Incannex Healthcare Inc. - Common Stock (NQ: IXHL )
8.730 +1.580 (+22.10%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2023 Add to My Watchlist
All News about Incannex Healthcare Inc. - Common Stock
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief medical officer Dr Mark Bleakley speaks with Proactive soon after announcing final results for a Phase 1 clinical trial to assess pharmacokinetics...
Incannex to work with Catalent to produce psilocybin for clinical and potentially commercial use
March 03, 2023
Incannex Healthcare Ltd (ASX:IHL NASDAQ:IXHL) CEO and MD Joel Latham sits down with Proactive to talk about the development and manufacturing deal it has struck with pharma giant Catalent to produce...
Incannex Healthcare kicks off Phase 2 rheumatoid arthritis trial
February 28, 2023
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has begun a Phase 2 clinical trial, testing the safety and efficacy of its IHL-657A drug candidate in patients...